Table 4 Diabetic patients stratified by statin use prior to first myocardial infarction
On statins before MI | Not on statins before MI | p value | |
|---|---|---|---|
n = 106 | n = 122 | ||
Gender, % | – | – | 0.51 |
Age, year | 70.1 (12.0) | 70.6 (15.2) | 0.80 |
Smoking, % | 34 | 37 | 0.21 |
Total cholesterol, mmol/L | 4.1 (1.2) | 4.8 (1.4) | <0.001 |
LDL cholesterol, mmol/L | 2.1 (0.9) | 2.9 (1.2) | <0.001 |
HDL cholesterol, mmol/L | 1.2 (0.4) | 1.2 (0.4) | 0.42 |
Triglycerides, mmol/L | 1.8 (1.6) | 1.9 (1.3) | 0.45 |
Systolic blood pressure, mmHg | 139 (21.5) | 138 (24.0) | 0.76 |
Hypertension, % | 89 | 71 | 0.001 |
Antihypertensive medicine, % | 79 | 60 | 0.002 |
GFRc, mL/min/1.73 m2 | 64 (27.3) | 72 (27.3) | 0.03 |
Nephropathy (GFR < 60)c, % | 43 | 33 | 0.69 |
Family history of CHD, % | 37 | 34 | 0.62 |
LDL cholesterol ≥2 mmol/L, % | 54 | 81 | <0.001 |
LDL cholesterol ≥1.8 mmol/L, % | 57 | 83 | <0.001 |
SCORE (mean), % | – | 3.8 (2.8) | |
SCORE (mean) before statin therapya, % | 4.6 (3.8) | – | |
Estimated 10-year risk in diabetes (mean)b, % | 16.6 (12.4) | 13.7 (10.2) | 0.10 |
Estimated 10-year risk in diabetes ≥5 %b, n/n | 91 % | 85 % | 0.22 |